Newtown, PA, United States of America

James Neels

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Newtown, PA (US) (2013 - 2017)
  • Holland, PA (US) (2019 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: James Neels: Pioneering Innovations in Potassium Ion Channel Inhibitors

Introduction:

James Neels, a visionary inventor based in Newtown, PA (US), is setting new standards in the field of pharmaceutical innovation. With a strong passion for creating a better future through his inventions, Neels continues to inspire the next generation of inventors with his relentless pursuit of excellence.

Latest Patents:

Neels recently obtained two groundbreaking patents for "Quinazolines as Potassium Ion Channel Inhibitors." These compounds, designed to inhibit potassium channel function, show promising results in the treatment and prevention of arrhythmia and associated disorders. The formula he developed demonstrates his prowess in developing cutting-edge solutions for complex medical conditions.

Career Highlights:

With an impressive portfolio of 8 patents, Neels has made significant contributions to the pharmaceutical industry. His dedication to innovation and research has earned him recognition as a leading figure in inventing novel medical solutions. Neels is currently affiliated with Bristol-Myers Squibb Company, a renowned pharmaceutical firm.

Collaborations:

Neels has collaborated with accomplished professionals such as Heather J Finlay and John E Lloyd. Through these partnerships, he has leveraged collective expertise to push the boundaries of scientific discovery and pave the way for transformative inventions in the healthcare sector.

Conclusion:

James Neels' unwavering commitment to excellence and his remarkable achievements in the field of pharmaceutical innovation serve as a testament to his ingenuity. His groundbreaking work in developing potassium ion channel inhibitors not only underscores his impact on the industry but also highlights his enduring legacy as a trailblazing inventor shaping the future of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…